003017.SZ Stock Analysis
00
Uncovered
Zhejiang Dayang Biotech Group Co Ltd is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Zhejiang Dayang Biotech Group Co., Ltd. engages in the production and sales of potassium salt and veterinary drugs. The company is headquartered in Hangzhou, Zhejiang and currently employs 925 full-time employees. The company went IPO on 2020-10-26. The firm's main products include potassium carbonate, potassium bicarbonate, amproline hydrochloride, 2-chloro-6-fluorobenzaldehyde, etc. Its products are used in food, pesticide, fertilizer, medicine and glass fields. The firm conducts its businesses within the Chinese market and to overseas markets.